- Home
- AFCG vs GNTA Comparison
AFCG vs GNTA Comparison
Compare AFCG & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AFCG | GNTA |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | Italy |
| Employees | N/A | 9 |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.4M | 69.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | AFCG | GNTA |
|---|---|---|
| Price | $2.75 | $1.30 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 83.0K | 59.3K |
| Earning Date | 05-07-2026 | 03-24-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $24,563,601.00 | N/A |
| Revenue This Year | $1,334.03 | N/A |
| Revenue Next Year | $17.33 | N/A |
| P/E Ratio | $5.90 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.06 | $0.55 |
| 52 Week High | $5.10 | $10.00 |
Technical Indicators
Market Signals| Indicator | AFCG | GNTA |
|---|---|---|
| Relative Strength Index (RSI) | 43.46 | 41.18 |
| Support Level | $2.49 | $1.30 |
| Resistance Level | $2.78 | $1.70 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | 0.03 | -0.03 |
| Stochastic Oscillator | 50.00 | 20.00 |
Price Performance
Historical ComparisonAbout AFCG AFC Gamma Inc.
Advanced Flower Capital Inc is an externally managed Maryland corporation that operates as a Business Development Company (BDC). The firm's primary operations involve originating, structuring, underwriting, and managing senior secured loans and other debt securities. Its investment portfolio includes loans to state law-compliant cannabis operators, ancillary cannabis businesses, and middle-market companies in other industries. These loans are typically secured by collateral such as real estate, equipment, cash flows, and license values.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.